Oncogenic driver mutations predict outcome in a cohort of head and neck squamous cell carcinoma (HNSCC) patients within a clinical trial.
Fernández-Mateos J, Pérez-García J, Seijas-Tamayo R, Mesía R, Rubió-Casadevall J, García-Girón C, Iglesias L, Carral Maseda A, Adansa Klain JC, Taberna M, Vazquez S, Gómez MA, Del Barco E, Ocana A, González-Sarmiento R, Cruz-Hernández JJ.
Fernández-Mateos J, et al. Among authors: taberna m.
Sci Rep. 2020 Oct 6;10(1):16634. doi: 10.1038/s41598-020-72927-2.
Sci Rep. 2020.
PMID: 33024167
Free PMC article.